Optimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate. - Wikidata - awgldk - TriplyDB

Optimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate.

Optimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate.

http://www.wikidata.org/entity/Q37865056

about

7,8,4'-Trihydroxyisoflavone attenuates DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice.Off-label prescribing for allergic diseases in children.Topical Application of Eupatilin Ameliorates Atopic Dermatitis-Like Skin Lesions in NC/Nga Mice Atopic dermatitis in children: management of pruritus.Frontiers of rapid itch relief: a review of methylprednisolone aceponate.Chronic pruritus associated with dermatologic disease in infancy and childhood: update from an interdisciplinary group of dermatologists and pediatricians.Does therapeutic intervention in atopic dermatitis normalize epidermal Notch deficiency?The suppression of thymic stromal lymphopoietin expression by selenium.Health benefit of fucosterol from marine algae: a review.Development of a pharmacokinetic/pharmacodynamic/disease progression model in NC/Nga mice for development of novel anti-atopic dermatitis drugs.Methylprednisolone aceponate for atopic dermatitis.

P2860

Q34109984-B48AC8E5-E51A-4F0B-9279-9D868AED0CB9 Q37592152-B54CBE66-213A-48B3-98CE-4DC5B78C4AF4 Q37654057-06AFDD02-D7B9-4057-8A8D-711F4B5432F2 Q38052176-D48F517C-FB8D-4BA0-B765-DF9F170403C0 Q38052177-AFF6E5B1-BBC7-4E0D-A656-E318A0720DF3 Q38131810-EA27F453-F036-43F3-89E0-306C3CFA21BB Q38216934-397343C3-994C-4E83-AAF9-AA9174A7F314 Q38468608-F206BFE0-69A6-4441-9D25-8B9678908EDE Q38603969-A0B457D4-28D9-4452-9D11-70A9AC7BA57E Q38990396-C6484A5D-F75F-4B53-AD6C-95C38C73A386 Q39160898-B0C4BE52-5D74-4F8D-9AE3-3D8160E9DDD8

P2860

Optimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate.

http://www.wikidata.org/entity/Q37865056

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Optimizing the treatment of at ...... methylprednisolone aceponate.

@en

Optimizing the treatment of at ...... methylprednisolone aceponate.

@nl

type

label

Optimizing the treatment of at ...... methylprednisolone aceponate.

@en

Optimizing the treatment of at ...... methylprednisolone aceponate.

@nl

prefLabel

Optimizing the treatment of at ...... methylprednisolone aceponate.

@en

Optimizing the treatment of at ...... methylprednisolone aceponate.

@nl

P1433

Q37865056-0D7F4620-EA7A-4B26-BA28-342DCCC96218

P1476

Q37865056-F787D87E-65D2-4242-91A3-D10D06F835C7

P2093

Q37865056-72FA272F-BD09-4AB7-95B4-2A204887C22E

Q37865056-76308C71-0648-41B4-ADBF-8B44EFBA12C1

P2860

Q37865056-01FD0E3D-5C4D-4213-A6A0-08EA9279B2BE

Q37865056-2265745B-3F23-4F5A-8BE0-4DFEDF961B6C

Q37865056-22D0BA90-51AF-4752-B4C3-8BD313B17D9C

Q37865056-29E3B812-32D5-4174-B5C1-0AB5FF69AB5A

Q37865056-2A0C6E8C-CD84-4436-ABCC-6FB7BC10DF41

Q37865056-2E612AB3-663E-44DD-9E37-128378FE1165

Q37865056-32D9D6DF-95F4-4E5A-B3B4-A5CF17AF35A5

Q37865056-34418B95-4E3E-411E-B3F3-CC04FD67C5DD

Q37865056-39286EB9-57D1-4785-9868-011318A7C9E5

Q37865056-5AA62676-0C0D-4925-9572-DAD0BB370BD7

P304

Q37865056-0F7A1EAC-554F-404E-A309-A6AAAE82D154

P31

Q37865056-DF83776E-421C-4DFF-B21E-4816E7ED5D3A

P356

Q37865056-5316CA80-2975-4EC4-A40F-D674F837B119

P433

Q37865056-95AC4B85-51AC-416A-8DA9-CBD4E5287BEF

P478

Q37865056-0763DE9C-7BA2-4A5B-AD68-BB388B60781C

P577

Q37865056-2241B88A-214F-4616-9C8D-87323A23A47D

P698

Q37865056-B07350BF-AA56-42E0-9C24-8F312D1A57E8

P356

J.1468-3083.2010.03942.X

P1433

Journal of the European Academy of Dermatology and Venereology

P1476

Optimizing the treatment of at ...... methylprednisolone aceponate.

@en

P2093

U Blume-Peytavi

http://www.w3.org/2001/XMLSchema#string

U Wahn

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci

Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis

Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials.

Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children.

Adverse effects of topical glucocorticosteroids.

Atopic dermatitis and asthma: parallels in the evolution of treatment.

Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report.

Galenics of dermal products--vehicles, properties and drug release.

Prednicarbate: a review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders.

Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report.

P304

508-515

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1468-3083.2010.03942.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P577

2011-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21492244

http://www.w3.org/2001/XMLSchema#string